| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |